SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001387131-22-012413
Filing Date
2022-12-14
Accepted
2022-12-14 17:05:06
Documents
1
Group Members
DAVID BONDERMANJAMES G. COULTERJON WINKELRIED

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13D amrx-sc13da_121222.htm SC 13D/A 74066
  Complete submission text file 0001387131-22-012413.txt   75654
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 221462864
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 (817) 871-4000
TPG GP A, LLC (Filed by) CIK: 0001903793 (see all company filings)

IRS No.: 872054646 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A